Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|January 9, 2021

Shimadzu Medical Systems USA Releases X-ray Assist Technology

GLIDE Technology ™ is designed to provide individualized, motorized assistance to X-ray technologists, potentially reducing injuries and shortening exam time.

X-ray technologists could soon experience fewer work-related injuries thanks to new technology released for sale recently by Shimadzu Medical Systems USA.

Throughout the industry, shoulder injuries top the list for the most common injuries these imaging professionals experience, followed closely by back and wrist problems. Most of these issues are due to the physical exertion needed for a technologist to maneuver the X-ray equipment that is mounted in the ceiling.

For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.

To prevent such injuries and potentially shorten exam times, Shimadzu announced the North American sales release of its RADspeed Pro style edition with GLIDE Technology™ that is designed to reduce the physical burden on technologists. Specifically called POWER GLIDE™, the tool can instantly sense the force exerted by a technologist, calculate how much assist-force is needed, and activate the motor in real-time. Consequently, company representatives said, the experience is individualized for both large movements and detailed positioning adjustments.

According to company information, the GLIDE VIEW ™ technology is available in mobile X-ray systems and GLIDE ASSIST™ can be found in patient-side R/F systems.


Related to this article

Foundation Model-Based Chest X-Ray AI Software Gets FDA Nod
Reportedly one of the first FDA-cleared chest X-ray AI software platforms derived from a foundation model, the Chest Xray software facilitates detection and localization of lung nodules, pneumothorax, mediastinal abnormalities and other thoracic abnormalities.
Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.